Cogno Limited

As Australia's leading national clinical trials group for brain cancer, COGNO is dedicated to improving treatment and care, raising awareness, and enhancing endoflife care for patients affected by brain tumours through clinical trials research. COGNO develops, facilitates and promotes the use of groundbreaking clinical trials and translational research to improve survival and quality of life for patients with brain tumours. COGNO also provides education, professional development and mentoring opportunities to brain cancer healthcare specialists to facilitate implementation of new treatments and optimal care to people diagnosed with this devastating disease.